Caged Garcinia xanthones: Development since 1937

Current Medicinal Chemistry

Volumn 16, Issue 28, 2009, Pages 3775-3796

  Han, Q B ^a,b   Xu, H X ^b  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anticancer activity; Caged xanthone; Cytotoxicity; Gamboge; Garcinia; Guttiferae

Indexed keywords

ANTINEOPLASTIC AGENT; DESOXYMORRELLIN; DOCETAXEL; FLUOROURACIL; GAMBOGE; GAMBOGIC ACID; GAMBOGIC AMIDE; GAUDICHAUDIONE A; GAUDICHAUDIONE DERIVATIVE; GAUDICHAUDIONE H; ISOMORELLIN; MORELLIN; NEOGAMBOGIC ACID; NEUROTROPIC AGENT; PLANT MEDICINAL PRODUCT; PLANT RESIN; SCORTECHINONE B; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ACNE; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ASCITES TUMOR; BIOLOGICAL ACTIVITY; BIOMIMETICS; BIOSYNTHESIS; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CHEMICAL STRUCTURE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DERMATITIS; DIARRHEA; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; GARCINIA; GARCINIA GAUDICHAUDII; GARCINIA HANBURYI; GARCINIA MORELLA; GENITAL HERPES; GLIOBLASTOMA; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; INFRARED RADIATION; KIDNEY INJURY; LEUKEMIA; LEWIS CARCINOMA; LIVER CELL CARCINOMA; LIVER INJURY; LUNG CANCER; MASS SPECTROMETRY; NAUSEA AND VOMITING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PAIN; PANCREAS CANCER; REPEATED DRUG DOSE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN CARCINOMA; SOLID TUMOR; STOMACH CANCER; STOMACH CARCINOMA; STOMACH PAIN; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; GARCINIA; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MOLECULAR STRUCTURE; PLANT EXTRACTS; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHONES;

EID: 70450197675     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789104993     Document Type: Review

References (157)

1. Rao, B.S. Morellin, a constituent of the seeds of Garcinia morella. J. Chem. Soc., 1937, 853-855
2. Venkataraman, K. Garcinia morella. Proceed. Indian Nation. Sci. Acad., Part A: Phys. Sci., 1973, 39, 365-381
3. Kartha, G.; Ramachandran, G.N.; Bhat, H.B.; Nair, P.M.; Raghavan, V.K. V.; Venkataraman, K. The constitution of morellin. Tetrahedron Lett., 1963, 7, 459-472
4. Nicolaou, K.C.; Li, J. "Biomimetic" cascade reactions in organic synthesis: construction of 4-oxatricyclo-[4.3.1.0]decan-2-one systems and total synthesis of 1-o-methylforbesione via tandem Claisen rearrangement/Diels - Alder reactions. Angew. Chem. Int. Ed., 2001, 40, 4264-4268 (Pubitemid 33134973)
5. Tisdale, E.J.; Slobodov, I.; Theodorakis, E.A. Unified synthesis of caged Garcinia natural products based on a site-selective Claisen/Diels-Alder /Claisen rearrangement. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 12030-12035
6. Nicolaou, K.C.; Sasmal, P.K.; Xu, H. Biomimetically inspired total synthesis and structure activity relationships of 1-O-methyllateriflorone. 6π electrocyclizations in organic synthesis. J. Am. Chem. Soc., 2004, 126, 5493-5501 (Pubitemid 38596361)
7. Nicolaou, K.C.; Xu, H.; Wartmann, M. Biomimetric total synthesis of gambogin and rate acceleration of pericyclic reactions in aqueous media. Angew. Chem. Int. Ed., 2005, 44, 756-761 (Pubitemid 40203989)
8. Abbas, S.; Bhoumik, A.; Dahl, R.; Vasile, S.; Krajewski, S.; Cosford, N. D.P.; Ronai, Z.A. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma. Clin. Cancer Res., 2007, 13, 6769-6778
9. Asano, J.; Chiba, K.; Tada, M.; Yoshii, T. Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry, 1996, 41, 815-820
10. XU, Y.J.; Yip, S.C.; Kosela, S.; Fitri, E.; Hana, M.; Goh, S.H.; Sim, K.Y. Novel cytotoxic, polyprenylated heptacyclic xanthonoids from Indonesian Garcinia gaudichaudii (Guttiferae). Org. Lett., 2000, 2, 3925-3948
11. Thoisen, O.; Fahy, J.; Dumontet, V.; Chiaroni, A.; Riche, C.; Tri, M.V.; Sevenet, T. Cytotoxic prenylxanthones from Garcinia bracteata. J. Nat. Prod., 2000, 63, 441-446
12. Zhao, L.; Guo, Q.L.; You, Q.D.; Wu, Z.Q.; Gu, H.Y. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol. Pharm. Bull., 2004, 27, 998-1003.
13. Tao, Z.J.; Zhou, Y.L.; Lu, J.J.; Duan, W.H.; He, X.X.; Lin, L.P.; Ding, J. Caspase-8 preferentially senses the apoptosis-Inducing action of NG-18, a gambogic acid derivative, in human leukemia HL-60 cells. Cancer Biol. Ther., 2007, 6, 691-696 (Pubitemid 47328349)
14. Guo, Q.L.; Lin, S.S.; You, Q.D.; Gu, H.Y.; Yu, J., Zhao, L.; Qi, Q.; Liang, F.; Tan, Z.; Wang, X.T. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci., 2006, 78, 1238-1245 (Pubitemid 43179978)
15. Yi, T.; Yi, Z.; Cho, S.G.; Luo, J.; Pandey, M.K.; Aggarwal, B.B.; Liu, M. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res., 2008, 68, 1843-1850
16. Zhang, H.Z.; Kasibhatla, S.; Wang, Y.; Eric, J.; Guastella, J.; Tseng, B.; Drewe, J.; Cai, S.X. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg. Med. Chem., 2004, 12, 309-317
17. Gu, H.Y.; Guo, Q.L.; You, Q.D.; Liu, W.; Qi, Q.; Zhao, L.; Yuan, S.T.; Zhang, K. Gambogic acid induced apoptosis in human hepatoma SMMC-7721 cells with p53 and Bax up-regulated. Chin. J. Nat. Med., 2005, 3, 168-172 (Pubitemid 40790299)
18. Yang, Y.; Yang, L.; You, Q.D.; Nie, F.F.; Gu, H.Y.; Zhao, L.; Wang, X.T.; Guo, Q.L. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett., 2007, 256, 259-266
19. Wu, Z.Q.; Guo, Q.L.; You, Q.D.; Zhao, L.; Gu, H.Y. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol. Pharm. Bull., 2004, 27, 1769-1774
20. Qi, Q.; Gu. H.Y.; Yang, Y.; Lu, N.; Zhao, J.; Liu, W.; Ling, H.; You, Q.D.; Wang, X.T.; Guo, Q.L. Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis. J. Mol. Med., 2008, 86, 1367-1377
21. Qiang, L.; Yang, Y.; You, Q.D.; Ma, Y.J. ; Yang, L.; Nie, F.F.; Gu. H.Y.; Zhao, L.; Lu, N.; Qi, Q.; Liu, W.; Wang, X.T.; Guo, Q.L. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study. Biomed. Pharmacol., 2008, 75, 1083-1092
22. Guo, Q.L. Qi, Q.; You, Q.D.; Gu, H.Y.; Zhao, L.; Wu, Z.Q. Toxticological studies of gambogic acid and its potential targets in experimental animals. Basic Clin. Pharmacol. Toxicol., 2006, 99, 178-184
23. Zhou, Z.T.; Wang, J.W. Phase I human tolerability trial of gambogic acid. Chin. J. New Drugs, 2007, 16, 79-82.
24. Zhao, J.; Qi, Q.; Yang, Y.; Gu, H.Y.; Lu, N.; Liu, W.; Wang, W.; Qiang, L.; Zhang, L.B.; You, Q.D.; Guo, Q.L. Inhibition of α4 integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid. Eur. J. Pharmacol., 2008, 589, 127-131
25. Kasibhatla, S.; Jessen, K. A.; Maliartchouk, S.; Wang, J.Y.; English, N.M.; Drewe, J.; Qiu, L.; Archer, S.P.; Ponce, A.E.; Sirisoma, N.; Jiang, S.; Zhang, H.Z.; Gehlsen, K.R.; Cai, S.X.; Green, D.R.; Tseng, B. A role for transferrin receptor in trigerring apoptosis when targeted with gambogic acid. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 12095-12100 (Pubitemid 41291134)
26. Gu, H.Y.; You, Q.D.; Liu, W.; Yang, Y.; Zhao, L.; Qi, Q.; Zhao, J.; Wang, J.; Lu, N.; Ling, H.; Guo, Q.L.; Wang, X. T. Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice. Int. Immunopharmacol., 2008, 8, 1493-1502
27. Zhai, D.Y.; Jin, C.F.; Shiau, C.W.; Kitada, S.; Satterthwait, A.C.; Ree, J.C. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins. Mol. Cancer Ther., 2008, 7, 1639-1646
28. Wang, T.; Wei, J.; Qian, X.; Ding, Y.; Yu, L.; Liu, B.. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett., 2008, 262, 214-222
29. Qin, Y.X.; Meng, L.H.; Hu, C.X.; Duan, W.H.; Zuo, Z.L.; Lin, L.P.; Zhang, X.W.; Ding, J. Gambogic acid inhibits the catalytic activity of human topoisomerase IIα by binding to its ATPase domain. Mol. Cancer Ther., 2007, 6, 2429-2440 (Pubitemid 47480408)
30. Gu, H.Y.; Wang, X.T.; Rao, S.Y.; Wang, J.; Zhao, J.; Ren, F.L.; Mu, R.; Yang, Y.; Qi, Q.; Liu, W.; Lu, N.; Ling, H.; You, Q.D.; Guo, Q.L. Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells. Mol. Cancer Ther., 2008, 7, 3298-3305
31. Wang, X.; Chen, Y.; Han, Q.B.; Chan, C. Y.; Wang, H.; Liu, Z.; Cheng, C. H.; Yew, D.T.; Lin, M.M.C.; He, M.L.; Xu, H.; Sung, J.; Kung, H.F. Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma. Proteomics, 2009, 9, 242-253
32. Mandal, S.; Das, R.C.; Joshi, P.C. Naturally occurring xanthones from terrestrial flora. J. Indian Chem. Soc., 1992, 69, 611-636
33. Peres, V.; Nagem, T.J. Trioxygenated naturally occurring xanthones. Phytochemistry, 1997, 44, 191-214.
34. Roberts, J.C. Natrually occurring xanthones. Chem. Rev., 1961, 61, 591-605.
35. Carpenter, I.; Locksley, H.D.; Scheinmann, F. Xanthones in higher plants: Biogenetic proposals and a chemotaxonomic survey. Phytochemistry, 1969, 8, 2013-2025
36. Hostettmann, K.; Wagner, H. Xanthone glycosides. Phytochemistry, 1977, 16, 821-829
37. Afzal, M.; Al-Hassan, J.M. Synthesis and biosynthesis of phytoxanthones. Heterocycles, 1980, 14, 1173-1205
38. Bennet, G.J.; Lee, H.H. Xanthones from guttiferae. Phytochemistry, 1989, 28, 967-998
39. Peres, V.; Nagem, T.J.; Oliveira, F.F. Tetraoxygenated naturally occurring xanthanones. Phytochemistry, 2000, 55, 683-710.
40. Zou, M.H.; Du, L.Q.; Zeng, H.; Luo, L.F.; Zhang, H.Z.; Lu, C.Z. Advances of development and utilization of Garcinia resources. Chin. J. Tropic. Crops, 2007, 28, 122-127
41. Rao, P.L.N.; Verma, S.C.L. Antibiotic principles of Garcinia morella. Part. II. Chemistry of Morellin. J. Sci. Ind. Res., 1952, 11B, 206-208
42. Rao, P.L.N.; Murthy, D.V.K.; Verma, S.C.L. Antibiotic principles of garcinia morella. Constitution of morellin. Naturwissenschaften, 1954, 41, 66-145
43. Bringi, N.V.; Shah, K.H.; Venkataraman, K. The colouring matters of Garcinia Morella: Part I. J. Sci. Ind. Res., 1955, 14B, 135-152
44. Bringi, N.V.; Padhye, M.R.; Venkataraman, K. The colouring matters of Garcinia Morella: Part I. Infrared and ultraviolet absorption spectra of morellin and its reduction products. J. Sci. Ind. Res., 1956, 15B, 128-138
45. Nair, P.M.; Venkataraman, K. The colouring matters of Garcinia morella: Part I. Isomorellin. Indian J. Chem., 1964, 2, 402-404
46. Bhat, H.B.; Nair, P.M.; Venkataraman, K. The colouring matters of Garcinia morella: Part V. Isolation of desoxymorellin & dihydroisomorellin. Indian J. Chem., 1964, 2, 405-410
47. Rao, K.V.N.; Rao, P.L.N. α- and β-Guttiferins. Experientia, 1961, 17, 213-214
48. Karanjgaonkar, C.G.; Nair, P.M.; Venkataraman, K. Morellic, isomorellic and gambogic acid. Tetrahedron Lett., 1966, 7, 687-691
49. Adawadkar, P.D.; Srinivasan, R.; Yemul, S.S. Coloring matters of Garcinia morella: Part VIII. Morellinol, dihydromorelloflavone and morelloflavone- 7″-β-glucoside. Indian J. Chem. Sect. B, 1976, 14, 19-21.
50. Rao, G.S.R.S.; Rathanamala, S.; Sivaramakrishnan, R. Structure of morellin, a pigment isolated from Garcinia morella Desser. Proc. Indian Acad. Sci., 1978, 87(4), 75-86.
51. Yates, P.; Karmarkar, S.S.; Rosenthal, D.; Stout, G.H.; Stout, V.F. Acetyl-α-gambogic acid. Tetrahedron Lett., 1963, 4, 1623-1629
52. Ollis, W.D.; Ramsay, M.V.J.; Sutherland, I.O. The constitution of gambogic acid. Tetrahedron, 1965, 21, 1453-1470
53. Kew Bulletin, Siam gamboge. Amer. J. Pharm., 1895, 67 (10), 3-4.
54. Hanbury, D. XXIII. On the species of Garcinia which affords gamboge in Siam. Zoolog. J. Linn. Soc., 1863, 24, 487-490
55. Han, Q.B.; Song, J.Z.; Qiao, C.F.; Xu, H.X. Characterization and quantitative analysis of xanthones in Gamboge. Chin. J. Nat. Med., 2006, 4, 210-214
56. Song, J.Z.; Yip, Y.K.; Han, Q.B.; Qiao, C.F.; Xu, H.X. Rapid determination of polyprenylated xanthones in gamboge resin of Garcinia hanburyi by HPLC. J. Sep. Sci., 2007, 30, 304-309
57. Li, S.L.; Song, J.Z.; Han, Q.B.; Qiao, C.F.; Xu, H.X. Improved high performance liquid chromatographic method for simultaneous determination of 12 cytotoxic caged xanthones in gamboge, a potential anticancer resin from Garcinia hanburyi. Biomed. Chromatogr., 2008, 22, 637-644
58. Elisabeth, F. In Artists' pigments: a handbook of their history and characteristics, Vol.1, Cambridge University Press, Ed. Feller, R. L.; Roy, A. F.; Elisabeth, W. B.; Barbara, H. Cambridge, United Kingdom, 1986, p 145.
59. Lin, L.J.; Lin, L.Z.; Pezzuto, J.M.; Cordell, G.A. Isogambogic acid and isomorellinol from Garcinia hanburyi. Magn. Reson. Chem., 1993, 31, 340-347
60. Guo, Q.L.; You, Q.D.; Wu, Z.Q.; Yuan, S.T.; Zhao, L. General gambogic acid inhibited growth of human hepatoma SMCC-7721 cells in vitro and in nude mice. Acta Pharmacol. Sin., 2004, 25, 769-774 (Pubitemid 38736103)
61. Guo, Q.L.; Zhao, L.; You, Q.D.; Wu, Z.Q.; Gu, H.Y. Chin. Gambogic acid inducing apoptosis in human gastric adenocarcinom SGC-7901 cells. J. Nat. Med., 2004, 2, 106-110
62. Cardillo, G.; Merlini, L. Absolute configuration of carbon 2 in the chromene ring of gambogic acid. Tetrahedron Lett., 1967, 27, 2529-2530
63. Weakley, T.J.R.; Cai, S.X.; Zhang, H.Z.; Keana, J.F.W. Crystal structure of the pyridine salt of gambogic acid. J. Chem. Crystallogr., 2001, 31, 501-505 (Pubitemid 33388796)
64. Han, Q.B.; Yang, L.; Liu, Y.; Wang, Y.L.; Qiao, C.F.; Song, J.Z.; Xu, L.J.; Yang, D.J.; Chen, S.L.; Xu, H.X. Gambogic acid and epigambogic acid, C-2 epimers with novel anticancer effects from Garcinia hanburyi. Planta Med., 2006, 72, 281-284
65. Han, Q.B.; Song, J.Z.; Qiao, C.F.; Wong, L.; Xu, H.X. Preparative separation of gambogic acid and its C-2 epimer using recycling high-speed counter-current chromatograpy. J. Chromatogr. A, 2006, 1127, 298-301.
66. Han, Q.B.; Yang, L.; Wang, Y.L.; Qiao, C.F.; Song, J.Z.; Sun, H.D.; Xu, H.X. A pair of novel cytotoxic polyprenylated xanthanone epimers from gamboge. Chem. Biodiv., 2006, 3, 101-105
67. Lu, G.B.; Yang, X.X.; Huang, Q.S. Isolation and structure of neogambogic acid from gamboge. Acta Pharm. Sin., 1984, 19, 636-639
68. Reutrakul, V.; Anantachoke, N.; Pohmakot, M.; Jaipetch, T.; Sophasan, S.; Yoosook, C.; Kasisit, J.; Napaswat, C.; Santisuk, T.; Tuchinda, P. Cytotoxic and anti-HIV caged xanthones from the resin and fruits of Garcinia hanburyi. Planta Med., 2007, 73, 33-40.
69. Han, Q.B.; Wang, Y.L.; Yang, L.; Tso, T.F.; Qiao, C.F.; Song, J.Z.; Xu, L.J.; Chen, S.L.; Yang, D.J.; Xu, H.X. Cytotoxic polyprenylated xanthones from the resin of Garcinia hanburyi. Chem. Pharm. Bull., 2006, 54, 265-267
70. Sukpondma, Y. ; Rukachaisirikul, V. ; Phongpaichit, S. Antibacterial caged-retraprenylated xanthones from the fruits of Garcinia hanburyi. Chem. Pharm. Bull., 2005, 53, 850-852
71. Feng, F.; Liu, W.Y.; Chen, Y.S.; Guo, Q.L.; You, Q.D. Five novel prenylated xanthones from Resina Garciniae. J. Asian Nat. Prod. Res., 2007, 9, 735-741
72. Rukachaisirikul, V.; Phainuphong, P.; Sukpondma, Y.; Phongpaichit, S.; Taylor, W.C. Antibacterial caged-tetraprenylated xanthones from the stem bark of Garcinia scortechinii. Planta Med., 2005, 71, 165-170
73. Sukpondma, Y.; Rukachaisirikul, V.; Phongpaichit, S. Xanthone and sesquiterpene derivatives from the fruits of Garcinia scortechinii. J. Nat. Prod., 2005, 68, 1010-1017
74. Rukachaisirikul, V.; Koysomboon, S.; Taylor, W. C.; Wanrudee, K.; Souwalak, P. Caged-tetraprenylated xanthones from Garcinia scortechinii. Tetrahedron, 2000, 56, 8539-8543
75. Rukachaisirikul, V.; Painuphong, P.; Sukpondma, Y.; Koysomboon, S.; Sawangchote, P.; Taylor, W. C. Caged-triprenylated and -tetraprenylated xanthones from the latex of Garcinia scortechinii. J. Nat. Prod., 2003, 66, 933-938
76. Wu, J.; Xu, Y.J.; Cheng, X.F.; Harrison, L.J.; Sim, K.Y.; Goh, S.H. A highly rearranged tetraprenylxanthonoid from Garcinia gaudichaudii (Guttiferae). Tetrahedron Lett., 2001, 42, 727-729
77. Cao, S.G.; Wu, X.H.; Sim, K.Y.; Tan, B.K.H.; Pereira, J.T.; Wong, W.H.; Hew, N.F.; Goh, S.H. Cytotoxic caged tetraprenylated xanthonoids from Garcinia gaudichaudii (Guttiferae). Tetrahedron Lett., 1998, 39, 3353-3356 (Pubitemid 28198028)
78. Cao, S.G.; Sng, V.H.L.; Wu, X.H.; Sim, K.Y.; Tan, B.H.K.; Pereira, J.T.; Goh, S.H. Novel cytotoxic polyprenylated xanthonoids from Garcinia gaudichaudii (Guttiferae). Tetrahedron, 1998, 54, 10915-10924 (Pubitemid 28383771)
79. Wu, X.H.; Tan, B.K.H.; Cao, S.G.; Sim, K.Y.; Goh, S.H.. Two minor, cytotoxic caged xanthonoids from Garcinia gaudichaudii. Nat. Prod. Lett., 2000, 14, 453-458
80. Thoison, O.; Cuong, D.D.; Gramain, A.; Chiaroni, A.; Hung, N.V.; Sevenet, T. Further rearranged prenylxanthones and benzophenones from Garcinia bracteata. Tetrahedron, 2005, 61, 8529-8535
81. Shadida, K.A.; Shaari, K.; Abas, F.; Israf, D.A.; Hamzah, A.S.; Syakroni, N.; Saha, K.; Lajis, N.H. Cytotoxic caged-polyprenylated xanthonoids and a xanthone from Garcinia cantleyana. Phytochemistry, 2007, 68, 2537-2544
82. Khalid, R.M.; Jabit, M.L.; Abas, F.; Stanslas, J.; Shaari, K.; Lajis, N.H. Cytotoxic xanthones from the leaves of Garcinia urophylla. Nat. Prod. Commun., 2007, 2, 271-276
83. Kosela, S.; Cao, S.G.; Wu, X.H.; Vittal, J.J.; Sukri, T.; Goh, S.H.; Kim, K.Y. Lateriflorone, a cytotoxic spiroxalactone with a novel skeleton, from Garcinia lateriflora Bl. Tetrahedron Lett., 1999, 40, 157-160
84. Leong, Y.W.; Harrison, L.J.; Bennett, G.J.; Tan, H.T.W. Forbesione, a modified xanthone from Garcinia forbesii. J. Chem. Res., 1996, 392-393
85. Mahabusarakam, W.; Nuangnaowarat, W.; Taylor, W.C. Xanthone derivatives from Cratoxylum cochinchinense roots. Phytochemistry, 2006, 67, 470-474
86. Laphookhieo, S.; Syers, J.K.; Kiattansakul, R.; Chantrapromma, K. Cytotoxic and antimalarial prenylated xanthones from Cratoxylum cochinchinense. Chem. Pharm. Bull., 2006, 54, 745-747
87. Reutrakul, V.; Santisuk, T.; Noessner, G.; Schmidt, J.; Nickel, B.; klenner, T.; Hose, S. Xanthone compounds, their preparation and use as medicament. US Pat., 2002, 6, 403,636 B1.
88. Yemul, S.S.; Rao, A.V.R. Electron-Impact-Induced fragmentation of morellin and related compounds. Organ. Mass Spectr., 1974, 9, 1063-1072
89. Feng, F.; Liu, W.Y.; Wang, Y.; Guo, Q.L.; You, Q.D. Structure elucidation of metabolites of gambogic acid in vivo in rat bile by high-performance liquid chromatography-mass spectrometry and high-performance liquid chromatography-nuclear magnetic resonance. J. Chromatogr. B, 2007, 860, 218-226
90. Rao, A.V.R.; Rathi, S.S.; Venkataraman, K. Electron-impact spectra of flavones with nuclear isoprenoid substituents. Indian J. Chem., 1972, 10, 989-1001.
91. Zhou, Y.; Liu, X.; Yang, J.; Han, Q.B.; Song, J.Z.; Li, S.L.; Ding, L.S.; Xu, H.X. Analysis of caged xanthones from the resin of Garcinia hanburyi using ultra-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Anal. Chim. Acta, 2008, 629, 104-118
92. Bennett, G.J.; Lee, H.H. Biosynthesis of mangostin: the origin of the xanthone skeleton. J. Chem. Soc., Chem. Commun., 1988, 619-620
93. Quillinan, A.J.; Scheinmann, F. Application of the Claisen rearrangement to the synthesis of heterocyclic bicyclo[2,2,2]octenones: an approach to the morellins based on new biogenetic suggestions. J. Chem. Soc., Chem. Commun., 1971, 966-968
94. Tisdale, E.J.; Chowdhury, C.; Vong, B.G.; Li, H.M.; Theodorakis, E. A. Regioselective synthesis of the bridged tricyclic core of Garcinia natural products via intramolecular aryl acrylate cycloadditions. Org. Lett., 2002, 4, 909-912
95. Tisdale, E.J.; Li, H.M.; Vong, B.G.; Kim, S.H.; Theodorakis, E.A. Regioselective synthesis of the tricyclic core of lateriflorone. Org. Lett., 2003, 5, 1491-1494 (Pubitemid 37140986)
96. Hayden, A.E.; Xu, H.; Nicolaou, K.C.; Houk, K.N. Origins of selectivity in pericyclic reaction cascades for the synthesis of gambogin and lateriflorone. Org. Lett., 2006, 8, 2989-2992
97. Li, N.G.; Wang, J.X.; Liu, X.R.; Lin, C.J.; You, Q.D.; Guo, Q.L. A novel and efficient route to the construction of the 4-oxa-tricyclo [4.3.1.0] decan-2-one scaffold. Tetraheron Lett., 2007, 48, 6586-6589
98. Bichan, D.J.; Yates, P. Two synthesis of the 2,4a-ethano-2,3,4,4a - tetrahydroxanthene system. J. Am. Chem. Soc., 1972, 94, 4773-4774
99. Raghavan, S.; Rao, G.S.R.S. Synthesis of 5,5-dimethyl-7-methoxy-4- oxatricyclo-[4.3.1.0]decan-2-ones. Heterocycles, 1994, 37, 131-136
100. Raghavan, S.; Rao, G.S.R.S. Synthesis based on cyclohexadienes: part 10. Synthesis of 5,5-dimethyl-7-methoxy-4-oxatricyclo [4.3.1.0] decan-2-ones. Tetrahedron, 1994, 50, 2599-2616 (Pubitemid 124018900)
101. Yates, P.; Auksi, H. The synthesis of bicyclo[2.2.2]actenones via intramolecular Diels-Alder reactions of modified Wessely oxidation products. Can. J. Chem., 1979, 57, 2853-2863
102. Mehta, G.; Maity, P. Construction of the 3-prenyl-4-oxa-tricyclo [4.3.1.0]-dec-8-en-one core of caged xanthonoid natural products via tandem Wessely oxidation-intramolecular [4+2] cycloaddition. Tetrahedron Lett., 2008, 49, 318-322. (Pubitemid 350235558)
103. Tisdale, E.J.; Slobodov, I.; Theodorakis, E. A. Biomimetic total synthesis of forbesione and desoxymorellin utilizing a tandem Claisen /Diels-Alder/Claisen rearrangement. Org. Biomol. Chem., 2003, 1, 4418-4422
104. Nicolaou, K.C.; Sasmal, P.K.; Xu, H.; Namoto, K.; Ritzen, A. Total synthesis of 1-O-methyllateriflorone. Angew. Chem. Int. Ed., 2003, 42, 4225-4229
105. Kuemmerle, J.; Jiang, S.C.; Tseng, B.; Kasibhatla, S.; Drewe, J.; Cai, S.X. Synthesis of caged 2,3,3a,7a-tetrahydro-3,6-methanobenzofuran -7(6H)-ones: Evaluating the minimium structure for apoptosis induction by gambogic acid. Bioorg. Med. Chem., 2008, 16, 4233-4241
106. Batova, A.; Lam, T.; Wascholowski, V.; Yu, A.L.; Giannis, A.; Theodorakis, E.A. Synthesis and evaluation of caged Garcinia xanthones. Org. Biomol. Chem., 2007, 5, 494-500.
107. Zhang, N.; Lu, H.G.; Deng, Y.; Wu, C.L. Clinical and laboratory research on the therapeutical effect of Garcinia morella Desv (GMD) in genital herpes. Chin. J. Dermatol., 2000, 33, 167-168
108. Zhang, N.; Cheng, B.; Ran, E.S. The observation of Garcinia morella Desv on treatment acne. J. Guiyang Med. Coll., 1993, 18, 138-140
109. Jang, S.W.; Okada, M.; Sayeed, I.; Xiao, G.; Stein, D. ; Jin, P. ; Ye, K. Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 16329-16334 (Pubitemid 350099404)
110. Wu, X.H.; Cao, S.G.; Goh, S.; Hsu, A.; Tan, B.K.H. Mitochondrial destabilisation and caspase-3 activation are involved in the apoptosis of Jurkat cells induced by gaudichaudione A, a cytotoxic xanthone. Planta Med., 2002, 68, 198-203.
111. Zhao, Q.; Yang, Y.; Yu, J.; You, Q.D.; Zeng, S.; Gu, H.Y.; Lu, N.; Qi, Q.; Liu, W.; Wang, X.T.; Guo, Q.L. Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells. Cancer Lett., 2008, 262, 223-231
112. 2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis, 2007, 28, 632-638
113. Yu, J.; Guo, Q.L.; You, Q.D.; Lin, S.S.; Li, Z. ; Gu, H.Y.; Zhang, H.W.; Tan, Z.; Wang, X. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother. Pharmacol., 2006, 58, 434-443 (Pubitemid 43999791)
114. Liu, W.; Guo, Q.L.; You, Q.D.; Zhao, L.; Gu, H.Y.; Yuan, S.T. Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J. Gastroenterol., 2005, 11, 3655-3659 (Pubitemid 41149258)
115. Liu, J.B.; Qin, S.K.; Li, J. Experimental research of anti-pancreatic cancer with gambogic acid. Chin. J. Clin. Oncol., 2005, 10, 274-277
116. Beringer, P.M.; Slaughter, R.L. Transporters and Their Impact on Drug Disposition. Ann. Pharmacother., 2005, 39, 1097-1108
117. Wang, J.; Liu, W.; Zhao, Q.; Qi, Q.; Lu, N.; Yang, Y.; Nei, F.F.; Rong, J.J.; You, Q.D.; Guo, Q.L. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology, 2009, 256, 135-40..
118. Wohrer, S.S.; Raderer, M.; Hejna, M. Palliative chemotherapy for advanced gastric cancer. Ann. Oncol., 2004, 15, 1585-1595 (Pubitemid 39567288)
119. Pandey, M.K.; Sung, B.; Ahn, K.S.; Kunnumakkara, A.B.; Chaturvedi ,M.M.; Aggarwal, B.B. Gambogic acid, a novel ligand for transferring receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-B signaling pathway. Blood, 2007, 110, 3517-3537
120. Chen, J.; Gu, H.Y.; Lu, N.; Yang, Y.; Liu, W.; Qi, Q.; Rong, J. J.; Wang, X. T.; You, Q.D.; Guo, Q.L. Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. Life Sci., 2008, 83, 103-109
121. Yang, N. Lu; Y.; You, Q.D.; Ling, Y.; Gao, Y.; Gu, H.Y.; Zhao, L.; Wang, X.T.; Guo, Q.L. Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. Cancer Lett., 2007, 258, 80-89 (Pubitemid 47600491)
122. Chen, Y.; Lin, M.C.; Yao, H.; Wang, H.; Zhang, A.Q.; Yu, J.; Hui, C.K.; Lau, G.K.; He, M.L.; Sung, J.; Kung, H.F. Lentivirus-mediated RNA interference targeting EZH2 inhibits hepatocellular carcinoma growth via down-regulation of stathmin. Hepatology, 2007, 46, 200-208
123. Ortiz-Sanchez, E.; Daniels, T.R.; Helguera, G.; Martinez-Maza, O.; Bonavida, B.; Penichet, M.L. Enhanced cytotoxicity of an antitransferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia, 2009, 23, 59-70.
124. Meyer, M.; Schreck, R.; Baeuerle, P.A. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J., 1993, 12, 2005-2015 (Pubitemid 23157717)
125. Nakano, H.; Nakajima, A.; Sakon-Komazawa, S.; Piao, J.H.; Xue, X.; Okumura, K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ., 2006, 13, 730-737
126. Toledano, M.B.; Leonard, W.J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 4328-4332 (Pubitemid 21914533)
127. Wang, Y.; Chen, Y.; Chen, Z.; Wu, Q.; Ke, W.J.; Wu, Q.L. Gambogic acid induces death inducer-obliterator 1-mediated apoptosis in Jurkat T cells. Acta Phamacol. Sin., 2008, 29, 349-354
128. Chinese Medicine Ordinance, Cap. 549 of the Laws of Hong Kong, 1999, schedule 1.
129. Sun, Z.; Jiang, X.Y.; Chen, W.Y.; Gao, W.X.; Li, Y.F.; Tan, Q.M. Some toxicities of injection gambogiae in mice and rats. Acta Acad. Med. Jiangxi, 1983, 23 (3), 5-8.
130. Hao, K.; Liu, X.Q.; Wang, G.J.. Pharmacokinetics of gambogic acid in rats. J. Chin. Pharm. Univ., 2005, 36, 338-341
131. Hao, K.; Liu, X.Q.; Wang, G.J.; Zhao, X.P. Pharmacokinetics, tissue distribution and excretion of gambogic acid in rats. Eur. J. Drug Metab. Pharmacokinet., 2007, 32, 63-68
132. Qi, Q.; You, Q.D.; Gu, H.; Zhao, L.; Liu, W.Y.; Lu, N.; Guo, Q.L. Studies on the toxicity of gambogic acid in rats. J. Ethnopharmacol., 2008, 117, 433-438
133. Guo, Q.L.; Zhao, L.; Wu, Z.Q.; You, Q.D.; Yu, G.; Zhang, Q. Effect of gambogic acid on the hemopoietic and immune fuctions in experimental animals. Chin. J. Nat. Med., 2003, 1, 229-232
134. Song, Q.S.; Zong, C.R.; Liu, D.H.; Huang, W.; Chen, J. Clinical trial of gamboge in the treatment of skin cancer. Pract. J. Cancer, 1986, 1(3), 46-48
135. Lin, Z.F. 126 application cases of gamboge ointment used in the treatment of breast phlegmonous abscess. J. Med. Theor. Pract., 1991, 4(6), 36.
136. Zhao, X.H.; Jiang, T.; Ling, S.Q. Eighty six application cases of gambogic acid used in the treatment of paederus dermatitis. J. Dermatol. Venereol., 1998, 20(4), 34.
137. Zou, T.J. The external use of gamboge in the treatment of skin diseases. J. Extern. Ther. Trad. Chin. Med., 2002, 11(6), 42.
138. Li, Z.C.; Deng, W.; Tu, C.; Wang, Q.Q. One hundred and sixty four application cases of gamboge tincture combined with TDP in the treatment of herpes zoster. Guizhou Med. J., 2007, 31, 640.
139. Anticancer Gamboge Research Team. The antitumor activity of gamboge and the clinical test report. Jiangxi Med. J., 1982, 17(3), 1-5.
140. Zhu, X.; Zhang, C.; Wu, X.L.; Tang, X.Y.; Ping, Q.E. Preparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivatives. Drug Dev. Ind. Pharm., 2008, 34, 2-9.
141. Liu, W.Y.; Feng, F.; Chen, Y.S.; You, Q.D.; Zhao, S.X. Studies on the structure of alkaline degradation of gambogic acid. Chin. J. Nat. Med., 2004, 2, 75-77
142. Rao, D.R.; Gurudutt, K.N.; Mamatha, S.; Rao, L.J.M. Guttiferic acid, a novel rearrangement product from minor chromenoxanthone pigments of Garcinia morella Desr. Magn. Reson. Chem., 2007, 45, 578-582
143. Han, Q.B.; Cheung, S.; Tai, J.; Qiao, C.F.; Song, J.Z.; Xu, H.X. Stability and cytotoxicity of gambogic acid and its derivative, gambogoic acid. Biol. Pharm. Bull., 2005, 28, 2335-2337
144. Sun, H.D.; Huang, S.X.; Han, Q.B. Diterpenoids from Isodon species and their biological activities. Nat. Prod. Rep., 2006, 23, 673-698 (Pubitemid 44455387)
145. Chen YC, Shen SC, Tsai SH. Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim. Biophys. Acta, 2005, 1743, 291-304.
146. Kondo, M.; Shibata, T.; Kumagai, T.; Osawa, T.; Shibata, N.; Kobayashi, M. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. USA, 2002, 99, 7367-7372 (Pubitemid 34568697)
147. Leung, C.H.; Grill, S.P.; Lam, W.; Han, Q.B.; Sun, H.D.; Cheng, Y.C. Novel mechanism of inhibition of nuclear factor-{kappa}B DNA-binding activity by diterpenoids isolated from Isodon rubescens, Mol. Pharmacol., 2005, 68, 286-297
148. Li, N.G.; You, Q.D.; Huang, X.F.; Wang, J.X.; Guo, Q.L.; Chen, X.G.; Li, Y.; Li, H.Y. Synthesis and antitumor activities of structure-related small molecular compounds of gambogic acid. Chin. Chem. Lett., 2007, 18, 659-662
149. Han, Q.B.; Yang, N.Y.; Tian, H.L.; Qiao, C.F.; Song, J.Z.; Chang, D.C.; Chen, S.L.; Luo, K.Q.; Xu, H,X. Xanthones with growth inhibition against HeLa cells from Garcinia xipshuanbannaensis. Phytochemistry, 2008, 69, 2187-2192
150. Chen, B.R. The study of antitumor ingredients of gamboge I. Isolation and identification of gambogic acid. Acta Acad. Med. Jiangxi, 1980, 20(2), 4-10.
151. Feng, F.; Liu, W.Y.; Chen, Y.S.; Guo, Q.L.; You, Q.D. Study on derivatives of gambogic acid. J. Chin. Pharm. Univ., 2005, 36, 302-305
152. Wang, J.X.; Zhao, L.; Hu, Y.; Guo, Q.L.; Zhang, L.; Wang, X.J.; Li, N.G.; You, Q.D. Studies on chemical structure modification and biology of a natural product, Gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid. Eur. J. Med. Chem., 2009, 44, 2611-2620
153. Qu, B.X.; Hao, X.G.; Li, D.H. The experimental studies on antineoplastic action of gambogic acid II. Chin. J. Clin. Oncol., 1991, 18, 50-52
154. Qu, B.X.; Ji, Y.Z.; Zhang, P.; Yu, S.P.; Li, D.H. The cytocidal kinetic effects of gamboge II on L1210 leukemic cells. Chin. J. Clin. Oncol., 1991, 18, 53-56
155. Cheng, H.; Peng, D.Y.; Wang, X.S.; Tang, L.J.; Huang, P.; Li, Q.L. Antitumor effects of neogambogic acid both in vivo and in vitro. Chin. Trad. Herb. Drugs, 2008, 39, 236-240
156. Xu, B.; Xing, C.; Li, M.; Guo, W.; Cui, J.R. Inhibitory effects of TH2 on human epithelial hepatoma cancer cells. Prog. Biochem. Biophys., 2007, 34, 503-508 (Pubitemid 47227796)
157. Han, Q.B.; Zhou, Y.; Feng, C.; Huang, S.X.; Xu, G.; Li, S.L.; Qiao, C.F.; Song, J.Z.; Chang, D.C.; Luo, K.Q.; Xu, H.X. Bioassay guided discovery of apoptosis inducers from gamboge by high-speed counter-current chromatography and high-pressure liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry, J. Chromatogr. B, 2009, 877, 401-407